Chinese herbal recall
This article was originally published in The Tan Sheet
Executive Summary
New York City-based Kingsway Trading Inc. is voluntarily recalling two of its Chinese herbal supplements because they contain aristolochic acid; the ingredient was found in Kingsway Trading's Expellin Extract and Cardioflex. Aristolochic acid has been linked to an increased risk of kidney cancer and in some cases kidney failure (1"The Tan Sheet" April 16, 2001, p. 9). An FDA district office in New York collected samples during a routine inspection and subsequent testing revealed the presence of the ingredient. The company issued a recall letter to customers Nov. 12...
You may also be interested in...
Aristolochia Renal Disease Link Reported In Two U.S. Cases
Aristolochic acid-containing botanicals were used by two individuals in the U.S. who developed end-stage renal disease, FDA reports in an April 4 letter urging health professionals to more closely monitor their patients' dietary supplement intake.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.